Citation Impact
Citing Papers
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
2003 StandoutScience
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Development and validation of the Nancy histological index for UC
2015 Standout
Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease
2011
EGFR Antagonists in Cancer Treatment
2008 Standout
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Changing Age Demographics of Inflammatory Bowel Disease in Ontario, Canada
2014
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs
2004
Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children
2009
Psoriasis
2009 Standout
Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis
2008
Asthma Genetics
2002
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
Pediatric modification of the Montreal classification for inflammatory bowel disease
2010
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
2009
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Importance of disrupted intestinal barrier in inflammatory bowel diseases
2010
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease
2015
Cryopyrin activates the inflammasome in response to toxins and ATP
2006 StandoutNature
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
2016
Incidence and Natural Course of Inflammatory Bowel Disease in Korea, 2006–2012
2015
Pattern Recognition Receptors and Inflammation
2010 Standout
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
2016
New Approaches to Gene Hunting in IBD
2004
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
ATP-sensitive potassium channels mediate survival during infection in mammals and insects
2007 StandoutNobel
DLG5 and OCTN
2004
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
2011
Inflammatory Bowel Disease
2009 Standout
Genetics of Inflammatory Bowel Diseases
2015
IBD5 is a General Risk Factor for Inflammatory Bowel Disease: Replication of Association with Crohn Disease and Identification of a Novel Association with Ulcerative Colitis
2003
Host–microbiota interactions in inflammatory bowel disease
2020
Functional variants of OCTN cation transporter genes are associated with Crohn disease
2004
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
2007 Standout
Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends
2010
Future biologic targets for IBD: potentials and pitfalls
2010
CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel Disease
2002
Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?
2005
Innate antimicrobial immunity in inflammatory bowel diseases
2010
The burden of inflammatory bowel disease in Europe
2013
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Autophagy in the Pathogenesis of Disease
2008 Standout
Inflammatory Bowel Disease
2002 Standout
Plant pathogens and integrated defence responses to infection
2001 StandoutNature
Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction
2005
Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates
2012
Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease
2007
Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis
2004
Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria
2005
Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?
2013
Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?
2013
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
2016
New genes in inflammatory bowel disease: lessons for complex diseases?
2006
Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases
2015
Genomewide Scans of Complex Human Diseases: True Linkage Is Hard to Find
2001
Psychological stress in IBD: new insights into pathogenic and therapeutic implications
2005
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
2014
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity
2000
Performance of interferon-gamma release assays in patients with inflammatory bowel disease: A systematic review and meta-analysis
2012
Association of NOD2 with Crohn's Disease in a homogenous Irish population
2003
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Variants in the 5q31 cytokine gene cluster are associated with psoriasis
2007
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics
2004
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
2006 Standout
NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?
2004
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
2006 Standout
The Inflammasomes
2010 Standout
The nuclear hormone receptor NHR-86 controls anti-pathogen responses in C. elegans
2019
A Genome Scan in 260 Inflammatory Bowel Disease-Affected Relative Pairs
2003
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Using a Genome-Wide Scan and Meta-analysis to Identify a Novel IBD Locus and Confirm Previously Identified IBD Loci
2002
Genome-wide search in Finnish families with inflammatory bowel disease provides evidence for novel susceptibility loci
2003
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
The molecular classification of the clinical manifestations of Crohn's disease
2002
Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine
2007
The Genetics of Inflammatory Bowel Disease
2007
Lessons to be learned from the NOD2 gene in Crohn's disease
2003
Points of control in inflammation
2002 StandoutNature
Genome-wide association studies for common diseases and complex traits
2005 Standout
Optimization of conventional therapy in patients with IBD
2011
Analysis of the IBD5 locus and potential gene-gene interactions in Crohn’s disease
2003
A Genome Scan in 260 Inflammatory Bowel Disease-Affected Relative Pairs
2004
The global burden of IBD: from 2015 to 2025
2015 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren
2010 Standout
Pathogen Recognition and Innate Immunity
2006 Standout
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
2014
The plant immune system
2006 StandoutNature
The Clustering of Other Chronic Inflammatory Diseases in Inflammatory Bowel Disease: A Population-Based Study
2005
Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China
2016
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Current status of genetics research in inflammatory bowel disease
2005
Adherence to Medication
2005 Standout
Association with Selected Bacteria Does Not Cause Enterocolitis in IL-10 Gene-Deficient Mice Despite a Systemic Immune Response
2005
Review article: the natural history of postoperative C rohn's disease recurrence
2012
Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia
2015
Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease
2002
NETWORK COMMUNICATIONS: Lymphotoxins, LIGHT, and TNF
2004
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases
2015
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
2018
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis
2013
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
The Caenorhabditis elegans ARIP-4 DNA helicase couples mitochondrial surveillance to immune, detoxification, and antiviral pathways
2022 StandoutNobel
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
2005 StandoutScience
Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
2013
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial
2016
Budesonide for induction of remission in Crohn's disease
2015
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
2005
Time‐to‐reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease
2019
Clinical Implications of Inflammatory Bowel Disease Genetics on Phenotype
2005
The Structure of Haplotype Blocks in the Human Genome
2002 StandoutScience
CATERPILLER: A Novel Gene Family Important in Immunity, Cell Death, and Diseases
2004
Works of Alain Bitton being referenced
Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Tumour Necrosis Factor-Alpha Antagonist Therapy in Crohn’s Disease
2009
Relationship Between Proximal Crohn's Disease Location and Disease Behavior and Surgery: A Cross-Sectional Study of the IBD Genetics Consortium
2012
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
2015
Direct and Indirect Induction by 1,25-Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn Disease
2009
Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial
2002
Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology
2014
CARD15 Genetic Variation in a Quebec Population: Prevalence, Genotype-Phenotype Relationship, and Haplotype Structure
2002
Epidemiology of Crohnʼs Disease in QuéBec, Canada
2008
Genomewide Search in Canadian Families with Inflammatory Bowel Disease Reveals Two Novel Susceptibility Loci
2000
Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review
2018
Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
2008
Review article: defining remission in ulcerative colitis
2011
Association of DLG5 R30Q variant with inflammatory bowel disease
2005
The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients
2015
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohnʼs disease: A randomized, double-blind, placebo-controlled pilot study
2008
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
2015
Association between genetic variants in the HNF4A gene and childhood-onset Crohn’s disease
2012
Patient Nonadherence To Medication in Inflammatory Bowel Disease
2003
Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn's disease: A systematic review and meta-analysis
2014
Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements
2011
Psychosocial correlates of patient-physician discordance in inflammatory bowel disease
2002
The role of endoscopy in the evaluation of pouches and ostomies
2002
Epidemiology of Inflammatory Bowel Disease in Québec
2014
Psychosocial Determinants of Relapse in Ulcerative Colitis: A Longitudinal Study
2003
Incidence Trends for Crohnʼs Disease and Ulcerative Colitis in the Province of Québec, Canada
2013
Inflammatory Bowel Disease: A Canadian Burden of Illness Review
2012
M1207 A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease
2008
760 Divergence in L4 Crohn's Disease: Jejunal, Not Esophagogastroduodenal Involvement, is Protective of L2 Disease Location, and a Risk for Stricturing Behavior and Multiple Abdominal Surgeries. Report From the NIDDK-IBDGC Registry
2010
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease
2013
Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
2013
Mesalamine-induced lung toxicity.
1996